Toshiyuki Karumori

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Patient Reported Outcomes

Health Insurance

Prognostic Factors

Mesenchymal Stem Cells

Top Venues

Drugs - real world outcomes

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of blood medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes 11 (3) (2024)
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes 11 (3) (2024)
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes 11 (3) (2024)
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes (2024)
Katsuyuki Fukutake, Kanae Togo, Linghua Xu, Leona E Markson, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B. Journal of blood medicine 14 (2023)
Katsuyuki Fukutake, Masashi Taki, Tadashi Matsushita, Michio Sakai, Ami Takata, Hiromi Yamaguchi, Toshiyuki Karumori
Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)